Diapharma/Multiplate® TRAPtest, 3x1ml/08116679001/Kit/3x1ml

Description:

Multiplate®TRAPtest isareagentkit usedforplateletaggregationresearchstudiesfortheevaluationofnormalplateletfunctionontheMultiplate®Analyzerand fortheresearchevaluationofqualitativeplateletfunctioninhibition.Sensitivetotheactionofglycoprotein (Gp)IIb/IIIareceptorantagoNISTsand/or adeficiencyof GpIIb/IIIareceptors.

Pleasenotethecatalog#forMultiplate®TRAPtestKithaschangedto08116679001.Youmayhavepreviouslyorderedthisproductundercatalog#sMP0250or 0675883190.

KitComposition:

Reagents,StorageandStABIlity

• 08116679001:Multiplate®TRAPtestreagent, Kit,3x1.0mL.150tests. Reagentisstableuntiltheexpirationdateprintedonthe viallabelwhenstoredat2-8°C. Stable7daysafterreconstitutionwhenstoredat 2-8°C.Stable4weeksafterreconstitutionwhen storedat<-20°C.Stablefor24hoursatroom temperatureafteronetimethawing.

Alsoavailable

• 06675727190: Multiplate®TRAPtestAliquotVials,Box, 100 colorcoded(yellow)microtesttubes.

Nolongeravailable

• MP0150:Multiplate®TRAPtestreagent,Bag, 1x1.0mL,5colorcoded(yellow)microtesttubesfor aliquotation.50tests.
• MP0195:Multiplate®TRAPtest reagent,Kit,1x1.0mL.50tests.

MeasurementPrinciple:

IntheTRAPtest,plateletsareactivatedbyTRAP-6,apeptidethatmimicstheactivationofplateletsbytheactionofthrombin.Thrombinisthemostpotentplateletactivator.TheactionofthrombinisnotblockedbytheantiplateletagentsAspirin®orclopidogrel.However,thrombin(andTRAP-6)activatedplateletsareblockedbytheactionofGPIIb/IIIaantagonists(e.g.,ReoPro®,Aggrastat®andIntegrilin®).

Mission Statement

Diapharma Group, Inc. in West Chester, Ohio sells hemostasis, thrombosis, platelet function testing, instrumentation, and apoptosis products in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.

diapharma hemostasis chromogenic clotting elisa assay test kit

History

The Diapharma Group, Inc. formed on January 1, 1997 from Pharmacia Hepar, Inc. in Franklin, Ohio, and began as the exclusive US and Canadian distributor of the Chromogenix substrates and assays.

Over a quarter-century ago, Chromogenix developed the first chromogenic substrate technology under the former name, Kabi Diagnostica. Kabi later merged with Pharmacia. Some of Diapharma’s current staff worked inside the Chromogenix department within Pharmacia’s heparin manufacturing plant.

In 1998, Diapharma moved to West Chester, Ohio, where it remains today. Over the years, Diapharma expanded its product line to include a variety of hemostasis, cell death, platelet function, ecotoxicology, assays, reagents, antibodies and instruments from superior manufacturers.

In 2017, Diapharma celebrated twenty years of success